LXEO Bear Put Spread Strategy
LXEO (Lexeo Therapeutics, Inc. Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.
LXEO (Lexeo Therapeutics, Inc. Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $452.3M, a beta of 1.53 versus the broader market, a 52-week range of 2.43-10.99, average daily share volume of 884K, a public-listing history dating back to 2023, approximately 75 full-time employees. These structural characteristics shape how LXEO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.53 indicates LXEO has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a bear put spread on LXEO?
A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width.
Current LXEO snapshot
As of May 15, 2026, spot at $5.09, ATM IV 17.00%, IV rank 0.00%, expected move 4.87%. The bear put spread on LXEO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this bear put spread structure on LXEO specifically: LXEO IV at 17.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a LXEO bear put spread, with a market-implied 1-standard-deviation move of approximately 4.87% (roughly $0.25 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LXEO expiries trade a higher absolute premium for lower per-day decay. Position sizing on LXEO should anchor to the underlying notional of $5.09 per share and to the trader's directional view on LXEO stock.
LXEO bear put spread setup
The LXEO bear put spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LXEO near $5.09, the first option leg uses a $5.09 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LXEO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LXEO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $5.09 | N/A |
| Sell 1 | Put | $4.84 | N/A |
LXEO bear put spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit.
LXEO bear put spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bear put spread on LXEO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bear put spread on LXEO
Bear put spreads on LXEO reduce the cost of a bearish LXEO stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
LXEO thesis for this bear put spread
The market-implied 1-standard-deviation range for LXEO extends from approximately $4.84 on the downside to $5.34 on the upside. A LXEO bear put spread caps both the risk and the reward of a bearish position; relative to an outright long put on LXEO, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current LXEO IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LXEO at 17.00%. As a Healthcare name, LXEO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LXEO-specific events.
LXEO bear put spread positions are structurally moderately bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LXEO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LXEO alongside the broader basket even when LXEO-specific fundamentals are unchanged. Long-premium structures like a bear put spread on LXEO are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current LXEO chain quotes before placing a trade.
Frequently asked questions
- What is a bear put spread on LXEO?
- A bear put spread on LXEO is the bear put spread strategy applied to LXEO (stock). The strategy is structurally moderately bearish: A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width. With LXEO stock trading near $5.09, the strikes shown on this page are snapped to the nearest listed LXEO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are LXEO bear put spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit. For the LXEO bear put spread priced from the end-of-day chain at a 30-day expiry (ATM IV 17.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LXEO bear put spread?
- The breakeven for the LXEO bear put spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current LXEO market-implied 1-standard-deviation expected move is approximately 4.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bear put spread on LXEO?
- Bear put spreads on LXEO reduce the cost of a bearish LXEO stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
- How does current LXEO implied volatility affect this bear put spread?
- LXEO ATM IV is at 17.00% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.